Breaking News: Blueberries Medical to Present at 2019 GMP Securities’ Global Cannabis Conference

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) (FRA: 1OA) a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company’s executive management team will attend and present at GMP Securities’ 2019 Global Cannabis Conference on April 16, 2019 at The Ritz-Carlton, Toronto.

The GMP Securities’ Global Cannabis Conference will explore current investing trends, industry perspectives on consumer trends and key developments. This full day event includes company presentations, panel discussions and one-on-one meetings with senior management teams. The conference will also provide the opportunity for key industry participants and institutional investors to network and interact with a diverse group of highly regarded experts, leaders and visionaries from leading public and private cannabis companies. Details of the Company’s presentation are below:

Presenter: Dr. Patricio Stocker, Chief Executive Officer
Date: Tuesday April 16, 2019
Time: 2:10 PM
Location: Presentation Room B (The Wellington Ballroom, 4th Floor), The Ritz-Carlton, Toronto

Dr. Stocker will discuss his extensive experience in cannabis cultivation in Colombia, his vision as well as the Company’s recent operational developments including the Company’s Colombian operations, entry into Argentina, extraction facility build-out and their strategic global relationships.

“Having recently completed our public listing, we are keen to increase market awareness and this conference will provide us an excellent platform for a formal introduction to the institutional investment community,” stated Dr. Patricio Stocker, Chief Executive Officer of the Company. “As we continue to execute on our operational plans and position ourselves as leaders in Latin America, we believe there is a great opportunity for investors to participate in the growth of our company.”

About Blueberries Medical Corp.
Blueberries is a Colombia-based licensed producer of naturally grown, premium quality cannabis with operations located in the Bogotá savannah of central Colombia and is also in the process of developing a Joint Venture with an Argentinian state-owned company for the development of a medicinal cannabis in Argentina. Led by a specialized team with proprietary expertise in agriculture, genetics, extraction, medicine, pharmacology and marketing, Blueberries has received all licenses required for the cultivation, production, domestic distribution, and international export of CBD (cannabidiol) and THC (tetrahydrocannabinol)-based medical cannabis in Colombia. Blueberries’ combination of leading scientific expertise, agricultural advantages, and distribution arrangements has positioned the Company to become a leading international supplier of naturally grown, processed, and standardized medicinal-grade cannabis oil extracts and related products.

Sponsored Content Release. Click for Full Disclosure

1 Comment
  1. Greg Harmon 6 days ago
    Reply

    I will be attending the Global Cannabis Conference, would love some time to speak to Stocker

Leave a Comment

  • Sponsored Content Release

    FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For blueberries medical corp. financial and corporate news dissemination, FinancialBuzz.com has been compensated ten thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.